Rita Jain
CIK: 0001707797
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Sep 30, 2026AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
1.3K shares at avg. $12.29- - Jun 30, 2026AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
1.1K shares at avg. $15.04- - Jun 25, 2026CLDX
Celldex Therapeutics, Inc.
Award(A)DirectNon-Qualified Stock Option (right to buy)
26K shares- - Jun 15, 2026TRAX
First Tracks Biotherapeutics, Inc.
Exercise(M)Direct7.3K shares- - Jun 2, 2026AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
20.1K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
7K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
2.5K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
15K shares- - May 12, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
42K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
10.6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
8K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
16.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
5.5K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
1.3K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
6K shares- - Apr 20, 2026TRAX
First Tracks Biotherapeutics, Inc.
Award(A)DirectRestricted Stock Unit
4K shares- - Mar 31, 2026AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
1.3K shares at avg. $12.13- - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Award(A)DirectStock Option (right to buy)
5.5K shares- - Jan 6, 2026ANAB
ANAPTYSBIO, INC
Award(A)DirectRestricted Stock Unit
4K shares- - Jan 5, 2026SABS
SAB Biotherapeutics, Inc.
Award(A)DirectStock Option (right to buy)
240K shares- - Dec 31, 2025AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
1K shares at avg. $14.74- - Sep 30, 2025AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
1.6K shares- - Jun 17, 2025AVTX
Avalo Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
40.2K shares- - Jun 15, 2025ANAB
ANAPTYSBIO, INC
Exercise(M)Direct7.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 |  AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 1,322 | $12.29 | - | Direct |
| Jun 30, 2026 | AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 1,080 | $15.04 | - | Direct |
| Jun 25, 2026 |  CLDX Celldex Therapeutics, Inc. | Award(A) Non-Qualified Stock Option (right to buy) | 26,000 | - | - | Direct |
| Jun 15, 2026 |  TRAX First Tracks Biotherapeutics, Inc. | Exercise(M) | 7,330 | - | $0 | Direct |
| Jun 2, 2026 | AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 20,100 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 7,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 2,500 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 15,000 | - | - | Direct |
| May 12, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 42,000 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,510 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 10,600 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 8,015 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 16,510 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 5,500 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 1,300 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 6,030 | - | - | Direct |
| Apr 20, 2026 | TRAX First Tracks Biotherapeutics, Inc. | Award(A) Restricted Stock Unit | 4,000 | - | - | Direct |
| Mar 31, 2026 | AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 1,339 | $12.13 | - | Direct |
| Jan 6, 2026 |  ANAB ANAPTYSBIO, INC | Award(A) Stock Option (right to buy) | 5,500 | - | - | Direct |
| Jan 6, 2026 | ANAB ANAPTYSBIO, INC | Award(A) Restricted Stock Unit | 4,000 | - | - | Direct |
| Jan 5, 2026 |  SABS SAB Biotherapeutics, Inc. | Award(A) Stock Option (right to buy) | 240,000 | - | - | Direct |
| Dec 31, 2025 | AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 1,043 | $14.74 | - | Direct |
| Sep 30, 2025 | AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 1,572 | - | - | Direct |
| Jun 17, 2025 | AVTX Avalo Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 40,200 | - | - | Direct |
| Jun 15, 2025 | ANAB ANAPTYSBIO, INC | Exercise(M) | 7,330 | - | - | Direct |
1-25 of 28 transactions
About Jain Rita
Jain Rita (SEC CIK 0001707797) files insider reports with the SEC as Director of Avalo Therapeutics, Inc. (AVTX), Director of Celldex Therapeutics, Inc. (CLDX) and Director of First Tracks Biotherapeutics, Inc. (TRAX). Signal8 also holds filings tied to 2 other companies.
Signal8 holds 20 ownership filings by Jain Rita (3 Form 3, 17 Form 4), filed between Jan 7, 2025 and Oct 2, 2026. Those filings report 28 transactions, from Jan 7, 2025 to Sep 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jain Rita's filings is in WAYNE, PA.
Recent filings by Jain Rita
- Sep 30, 2026: Grant or award of AVTX derivative securities (Form 4, code A).
- Jun 30, 2026: Grant or award of AVTX derivative securities (Form 4, code A).
- Jun 25, 2026: Grant or award of CLDX derivative securities (Form 4, code A).
- Jun 15, 2026: Option exercise of TRAX shares (Form 4, code M).
- Jun 2, 2026: Grant or award of AVTX derivative securities (Form 4, code A).
Other insiders filing for Avalo Therapeutics, Inc. (AVTX)
- Lind Kevin Robert, Director
- Philip Ron M, Director
- Sullivan Christopher Ryan, Chief Financial Officer
- Doyle Mittie, Chief Medical Officer
- Riley Jennifer, Chief Strategy Officer
- VARKI PAUL, Chief Legal Officer